The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RIBBON-UM: Treatment individualisation by EBV stratification in nasopharyngeal carcinoma (NPC): A phase 2, multi-arm umbrella platform trial.
 
Melvin Chua
Leadership - Digital Life Line
Stock and Other Ownership Interests - BeiGene (I); Digital Life Line
Honoraria - Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - Axiom Healthcare Strategies; BeiGene; Bicara Therapeutics; ImmunoSCAPE; IQVIA; Janssen Oncology; Merck Sharp & Dohme; PVmed; Seagen; Telix Pharmaceuticals
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; BeiGene; Janssen
Research Funding - Bayer (Inst); BeiGene (Inst); Decipher Biosciences; MVision; PVmed
Patents, Royalties, Other Intellectual Property - High Sensitivity Lateral Flow Immunoassay For Detection of Analyte in Samples (10202107837T), Singapore. (Danny Jian Hang Tng, Chua Lee Kiang Melvin, Zhang Yong, Jenny Low, Ooi Eng Eong, Soo Khee Chee)
(OPTIONAL) Uncompensated Relationships - Alice's Arc; American Joint Committee on Cancer Staging
 
Sze Huey Tan
No Relationships to Disclose
 
Enya Ong
No Relationships to Disclose
 
Wen Min Chow
No Relationships to Disclose
 
Britny H.S. Koh
No Relationships to Disclose
 
Jialing Neo
No Relationships to Disclose
 
Yoke Lim Soong
No Relationships to Disclose
 
Hui Lin Teo
No Relationships to Disclose
 
Elise Vong
No Relationships to Disclose
 
Mei-Kim Ang
No Relationships to Disclose
 
Jens Samol
No Relationships to Disclose
 
Darren Lim
No Relationships to Disclose